{"id":"https://openalex.org/W2910490263","doi":"https://doi.org/10.1016/j.dmpk.2018.09.041","title":"Site-specific deuterium substitution: A viable approach in drug discovery and development","display_name":"Site-specific deuterium substitution: A viable approach in drug discovery and development","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2910490263","doi":"https://doi.org/10.1016/j.dmpk.2018.09.041","mag":"2910490263"},"language":"en","primary_location":{"id":"doi:10.1016/j.dmpk.2018.09.041","doi":"https://doi.org/10.1016/j.dmpk.2018.09.041","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.dmpk.2018.09.041","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071827966","display_name":"MARGARET J. BRADBURY","orcid":"https://orcid.org/0000-0002-1998-5634","observed_orcids":["https://orcid.org/0000-0002-1998-5634"]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Bradbury","raw_affiliation_strings":["Consultant for Teva Pharmaceuticals, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant for Teva Pharmaceuticals, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057283760","display_name":"Edward T. Hellriegel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Hellriegel","raw_affiliation_strings":["Teva Pharmaceuticals, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027640751","display_name":"Yael Marantz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yael Marantz","raw_affiliation_strings":["Teva Pharmaceuticals, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceuticals, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065643172","display_name":"T.A. Baillie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Baillie","raw_affiliation_strings":["University of Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073573130","display_name":"David A. Stamler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Stamler","raw_affiliation_strings":["Prana Biotechnology, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prana Biotechnology, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.1104,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.31025039,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"34","issue":"1","first_page":"S8","last_page":"S9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deuterated-drugs","display_name":"deuterated drugs","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.5490000247955322},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.9160000085830688},{"id":"https://openalex.org/keywords/deuterium-labeling","display_name":"deuterium labeling","score":0.515999972820282},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.460999995470047},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2778220771","wikidata":"https://www.wikidata.org/wiki/Q1522579","display_name":"Substitution (logic)","level":2,"score":0.7760978937149048},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7181345820426941},{"id":"https://openalex.org/C58364064","wikidata":"https://www.wikidata.org/wiki/Q102296","display_name":"Deuterium","level":2,"score":0.5525479316711426},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5034000277519226},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49264222383499146},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4879245460033417},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41102269291877747},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26440322399139404},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2452496588230133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23825928568840027},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.1452333629131317},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12053683400154114},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.07373479008674622},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.dmpk.2018.09.041","doi":"https://doi.org/10.1016/j.dmpk.2018.09.041","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.dmpk.2018.09.041","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2523325143","https://openalex.org/W2169578341","https://openalex.org/W2970565279","https://openalex.org/W2783249434","https://openalex.org/W4410996482","https://openalex.org/W4256297060","https://openalex.org/W2560187113","https://openalex.org/W4396875427","https://openalex.org/W4410993710","https://openalex.org/W4245297681"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-01-25T00:00:00"}